GNFT - Barclays likes Genfit in premarket analyst action April, 22 2019 08:58 AM GENFIT S.A. Genfit (NASDAQ:GNFT) initiated with Overweight rating and $55 (120% upside) price target at Barclays.More news on: Genfit SA, Acceleron Pharma Inc., Retrophin, Inc., Healthcare stocks news, Read more ...